These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3158005)

  • 41. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V; Ahlenius S
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
    Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
    Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197).
    Tallentire D; McRae G; Spedding M; Clark R; Vickery B
    Br J Pharmacol; 1996 May; 118(1):63-72. PubMed ID: 8733577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of the aural head shake reflex in serotonin-mediated head shaking behavior.
    Lucki I; Eberle KM; Minugh-Purvis N
    Psychopharmacology (Berl); 1987; 92(2):150-6. PubMed ID: 3110836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central serotonin antagonist activity of ketanserin.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):151-4. PubMed ID: 6505385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketanserin attenuates the behavioural effects of corticosterone: implications for 5-HT(2A) receptor regulation.
    Gorzalka BB; Hanson LA; Hong JJ
    Eur J Pharmacol; 2001 Oct; 428(2):235-40. PubMed ID: 11675041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1984 Sep; 83(1):259-69. PubMed ID: 6487893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1990 Aug; 52(2):206-11. PubMed ID: 2148812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ; Commissaris RL; Warner MR; Rech RH
    J Pharmacol Exp Ther; 1983 Dec; 227(3):557-62. PubMed ID: 6655557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553.
    Sinclair-Worley L; Uphouse L
    Behav Brain Res; 2004 Jun; 152(1):129-35. PubMed ID: 15135976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A demonstration that 5-hydroxytryptamine administered peripherally can affect sexual behavior in male rats.
    Gonzales G; Mendoza L; Ruiz J; Torrejón J
    Life Sci; 1982 Dec; 31(24):2775-81. PubMed ID: 7154864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.
    Mokler DJ; Stoudt KW; Rech RH
    Pharmacol Biochem Behav; 1985 May; 22(5):677-82. PubMed ID: 3859879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies into the dual effects of serotonergic pharmacological agents on female sexual behaviour in the rat: preliminary evidence that endogenous 5HT is stimulatory.
    Hunter AJ; Hole DR; Wilson CA
    Pharmacol Biochem Behav; 1985 Jan; 22(1):5-13. PubMed ID: 3156384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selectively bred male rat lines differ in naïve and experienced sexual behavior.
    Sura A; Overstreet DH; Marson L
    Physiol Behav; 2001 Jan; 72(1-2):13-20. PubMed ID: 11239976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
    Callahan PM; Cunningham KA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1414-24. PubMed ID: 7562516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.